Hydroxypioglitazone - M-IV

Based on 16 reference(s) in Google Scholar 9 10 16

Axon 2533

CAS [146062-46-6]

MF C19H20N2O4S.HCl
MW 408.90

  • Purity: 100%
  • Soluble in DMSO

Hydroxypioglitazone

Description

Active metabolite of Pioglitazone (M-IV), a PPARγ agonist used for the treatment of diabetes mellitus type 2. Showed modest antihyperglycemic activity compared to Pioglitazone. Moreover, Hydroxypioglitazone is more efficient than Pioglitazone in stimulating lipid synthesis at a 3 µM dose in a 3T3-L1 cell assay.

KEYWORDS : Hydroxypioglitazone | supplier | PPARγ agonist | M-IV | CAS [146062-46-6] | [146062-44-4] | Prostaglandins | PPAR | Agonist | diabetes mellitus | type 2 | antihyperglycemic | Pioglitazone | metabolite

Order
Size Unit Price Stock
5 mg €235.00 In Stock
25 mg €800.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...